GB201205096D0 - Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity - Google Patents

Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Info

Publication number
GB201205096D0
GB201205096D0 GBGB1205096.9A GB201205096A GB201205096D0 GB 201205096 D0 GB201205096 D0 GB 201205096D0 GB 201205096 A GB201205096 A GB 201205096A GB 201205096 D0 GB201205096 D0 GB 201205096D0
Authority
GB
United Kingdom
Prior art keywords
iminosugars
dependent cell
mediated cytotoxicity
enhance antibody
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1205096.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GBGB1205096.9A priority Critical patent/GB201205096D0/en
Publication of GB201205096D0 publication Critical patent/GB201205096D0/en
Ceased legal-status Critical Current

Links

GBGB1205096.9A 2012-03-23 2012-03-23 Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity Ceased GB201205096D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1205096.9A GB201205096D0 (en) 2012-03-23 2012-03-23 Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1205096.9A GB201205096D0 (en) 2012-03-23 2012-03-23 Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Publications (1)

Publication Number Publication Date
GB201205096D0 true GB201205096D0 (en) 2012-05-09

Family

ID=46086972

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1205096.9A Ceased GB201205096D0 (en) 2012-03-23 2012-03-23 Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Country Status (1)

Country Link
GB (1) GB201205096D0 (en)

Similar Documents

Publication Publication Date Title
HK1212701A1 (en) Formulations of enzalutamide
HK1213798A1 (en) Therapeutic compounds and compositions
ZA201501709B (en) Cosmetic biphotonic compositions
HK1212906A1 (en) Vaccine compositions
HK1207819A1 (en) Oral composition
GB201222285D0 (en) Cellulose-derived compositions
EP2884984A4 (en) Therapeutic compositions and methods
GB201220354D0 (en) Dermal compositions
IL237431A0 (en) Immunogenic compositions
SI2874635T1 (en) Therapeutic bacteriophage compositions
EP2752186A4 (en) Skin cleanser composition
IL239569A0 (en) Anti-plaque oral compositions
EP2821053A4 (en) Skin cleanser composition
EP2897613A4 (en) Treatment compositions
HK1205954A1 (en) Companion cosmetic compositions
IL236312A0 (en) Preparation of 18f-fluciclovine
PL2734192T3 (en) Effervescent dosage form
EP2752185A4 (en) Skin cleanser composition
EP2821054A4 (en) Skin cleanser composition
GB201210873D0 (en) Therapeutic composition
IL217807A0 (en) Therapeutic compositions
HK1214755A1 (en) Dental compositions
EP2859881A4 (en) Oral composition
GB201205096D0 (en) Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity
GB201104878D0 (en) Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)